Pluri Inc. financial data

Symbol
PLUR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Matam Advanced Technology Park, Building No. 5, Haifa, Israel
State of incorporation
Nevada
Fiscal year end
June 30
Former names
PLURISTEM THERAPEUTICS INC (to 7/13/2022), PLURISTEM LIFE SYSTEMS INC (to 12/28/2007), AI SOFTWARE INC (to 7/1/2003)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 717 % -21%
Return On Equity -248 % -111%
Return On Assets -49.9 % +1.4%
Operating Margin -6.65 K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.39 M shares -86.9%
Common Stock, Shares, Outstanding 5.23 M shares -87.3%
Entity Public Float 34.4 M USD -23.3%
Weighted Average Number of Shares Outstanding, Basic 5.22 M shares +4.56%
Weighted Average Number of Shares Outstanding, Diluted 5.22 M shares +4.56%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 341 K USD -18.4%
Research and Development Expense 14.4 M USD -19.5%
General and Administrative Expense 10.4 M USD -14.4%
Operating Income (Loss) -22.7 M USD +23.4%
Nonoperating Income (Expense) 580 K USD
Net Income (Loss) Attributable to Parent -21.6 M USD +30%
Earnings Per Share, Basic -0.08 USD/shares +96.4%
Earnings Per Share, Diluted -0.08 USD/shares +96.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.08 M USD +92.6%
Cash, Cash Equivalents, and Short-term Investments 26.9 M USD
Accounts Receivable, after Allowance for Credit Loss, Current 3 K USD -84.2%
Assets, Current 27.4 M USD -41.4%
Property, Plant and Equipment, Net 769 K USD +12.9%
Operating Lease, Right-of-Use Asset 7.15 M USD -8.33%
Other Assets, Noncurrent 7 K USD +250%
Assets 36.4 M USD -35.3%
Employee-related Liabilities, Current 508 K USD -18.6%
Accrued Liabilities, Current 958 K USD -28.2%
Liabilities, Current 4.53 M USD -15.8%
Operating Lease, Liability, Noncurrent 5.34 M USD -11.3%
Retained Earnings (Accumulated Deficit) -415 M USD -5.5%
Stockholders' Equity Attributable to Parent -356 K USD -102%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.85 M USD -91.2%
Liabilities and Equity 36.4 M USD -35.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.86 M USD +23%
Net Cash Provided by (Used in) Investing Activities 5.8 M USD -9.24%
Common Stock, Shares Authorized 37.5 M shares -37.5%
Common Stock, Shares, Issued 5.23 M shares -87.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -97 K USD +93%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.99 M USD +74.4%
Deferred Tax Assets, Valuation Allowance 84.9 M USD +19.1%
Deferred Tax Assets, Gross 71.3 M USD +11.5%
Operating Lease, Liability 6.38 M USD -10.5%
Depreciation 67 K USD -33%
Payments to Acquire Property, Plant, and Equipment 103 K USD +41.1%
Lessee, Operating Lease, Liability, to be Paid 8.97 M USD
Property, Plant and Equipment, Gross 18.1 M USD +1.75%
Operating Lease, Liability, Current 675 K USD +7.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.12 M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17 M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.6 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.02 M USD
Deferred Tax Assets, Operating Loss Carryforwards 80.5 M USD +23.2%
Preferred Stock, Shares Authorized 1 M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 993 K USD
Additional Paid in Capital 414 M USD +0.53%
Deferred Tax Assets, Net of Valuation Allowance 84.9 M USD +19.1%
Share-based Payment Arrangement, Expense 43 K USD -23.2%
Interest Expense 868 K USD +0.46%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares